Mr. Leonard Osser will discuss future prospects, opportunities and the progress in commercial launch of the Issuer’s epidural and intra-articular drug delivery instruments in both Europe and the U.S.
The Board of Directors of the Issuer believes that participation in the conference will help the Company to more proactively communicate the business model to the investment community.
Members of the investment community interested in meeting the Company’s management during the conference should register at the following website: www.seethruequity.com.
Legal basis: Section 3.1 of the Exhibit 3 to the Alternative Trading System Rules “Current and Periodical Information in the Alternative Trading System on the NewConnect Market”.
Źródło:Komunikaty spółek (EBI)